title: [Sedural toxicity].
abstract: Phenazopyridine (Sedural) is widely used in the treatment of dysuria. It is considered a benign drug and most physicians are unaware of its potential toxicity. A 24-year-old woman who developed methemoglobinemia, acute renal failure and hemolytic anemia following a single 1 g dose of the drug is presented.
authors.affiliation: Dept. of Medicine T, Ichilov Hospital and Sackler School of Medicine, Tel Aviv University.
authors.forename: R
authors.initials: R
authors.lastname: Kornowski
authors.forename: M
authors.initials: M
authors.lastname: Averbuch
authors.forename: A
authors.initials: A
authors.lastname: Jaffe
authors.forename: D
authors.initials: D
authors.lastname: Schwartz
authors.forename: Y
authors.initials: Y
authors.lastname: Levo
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced*; D000328:Adult; D000743:Anemia, Hemolytic / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008708:Methemoglobinemia / Q000139:chemically induced*; D010621:Phenazopyridine / Q000009:adverse effects*
chemical_list: D010621:Phenazopyridine